Literature DB >> 29852267

High carriage rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae among patients admitted for surgery in Tanzanian hospitals with a low rate of endogenous surgical site infections.

N Moremi1, H Claus2, L Rutta3, M Frosch2, U Vogel2, S E Mshana3.   

Abstract

INTRODUCTION: Despite the high reported rates of surgical site infections (SSIs) caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (EPE) in low-income countries, including Tanzania, the role of EPE carriage in subsequent occurrence of SSIs is not known. This study investigated the rates of EPE carriage among surgical patients at the time of admission and discharge, and linked EPE genotype with SSIs.
METHODS: EPE were confirmed among isolates from rectal and wound/pus swabs using VITEK-2. Polymerase chain reaction and sequencing were performed to detect beta-lactamase genes. Multi-locus sequence typing was used to determine the genotypes of EPE isolates.
RESULTS: Among 930 patients enrolled, EPE carriage was significantly higher on discharge than admission (36.4% vs 23.7%, P<0.001). Of 272 patients who tested negative on admission, 78 (28.7%) acquired EPE during hospitalization. History of hospital stay within the previous three months was an independent predictor of EPE acquisition [hazard ratio 2, 95% confidence interval (CI) 1.04-3.98, P=0.038]. Of the 536 patients who were successfully followed-up after surgery, 78 (14.6%, 95% CI 11.6-17.5) developed SSIs. Of 57 SSIs investigated, 33 (58%) were caused by enteric Gram-negative bacteria, of which 63.6% (21/33) were EPE. Escherichia coli sequence type (ST)131 pandemic clone and Klebsiella pneumoniae ST391 predominated among wound isolates. The blaCTX-M-15 gene was detected in 37 (97.3%) of 38 ESBL isolates. Male sex was an independent predictor of SSI (odds ratio 2.92, 95% CI 1.73-4.91, P<0.001).
CONCLUSION: These findings warrant implementation of strict infection control measures, antimicrobial stewardship and exploration of the transmission dynamics of EPE in surgical wards.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Colonization; ESBL; Surgical site infection; Tanzania

Mesh:

Substances:

Year:  2018        PMID: 29852267     DOI: 10.1016/j.jhin.2018.05.017

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  12 in total

1.  Gastrointestinal Tract Colonization Rate of Extended-Spectrum Beta-Lactamase-Producing Gram-Negative Bacteria and Associated Factors Among Orthopaedic Patients in a Tertiary Hospital in Tanzania: Implications for Infection Prevention.

Authors:  Jeremiah Seni; Inyasi Lawrence Akaro; Baraka Mkinze; Zengo Kashinje; Modest Benard; Gerald Mboowa; Dickson Aruhomukama; Ivan Sserwadda; Moses L Joloba; Stephen E Mshana; Benson R Kidenya
Journal:  Infect Drug Resist       Date:  2021-05-11       Impact factor: 4.003

2.  The role of patients and healthcare workers Staphylococcus aureus nasal colonization in occurrence of surgical site infection among patients admitted in two centers in Tanzania.

Authors:  Nyambura Moremi; Heike Claus; Ulrich Vogel; Stephen E Mshana
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-17       Impact factor: 4.887

3.  High rates of multi-drug resistant gram-negative organisms associated with surgical site infections in a teaching hospital in Ghana.

Authors:  Antoinette A A Bediako-Bowan; Jørgen A L Kurtzhals; Kåre Mølbak; Appiah-Korang Labi; Enid Owusu; Mercy J Newman
Journal:  BMC Infect Dis       Date:  2020-11-25       Impact factor: 3.090

4.  High Carriage Rate of Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella Species among Poultry Meat Vendors in Dar es Salaam: The Urgent Need for Intervention to Prevent the Spread of Multidrug-Resistant Pathogens.

Authors:  Lutengano W Mwanginde; Mtebe Majigo; Debora C Kajeguka; Agricola Joachim
Journal:  Int J Microbiol       Date:  2021-03-03

5.  Extended-spectrum β-lactamase blaCTX-M-1 group in gram-negative bacteria colonizing patients admitted at Mazimbu hospital and Morogoro Regional hospital in Morogoro, Tanzania.

Authors:  Nyambura Moremi; Vitus Silago; Erick G Mselewa; Ashery P Chifwaguzi; Mariam M Mirambo; Martha F Mushi; Lucas Matemba; Jeremiah Seni; Stephen E Mshana
Journal:  BMC Res Notes       Date:  2021-02-27

6.  Comparison of hand hygiene compliance self-assessment and microbiological hand contamination among healthcare workers in Mwanza region, Tanzania.

Authors:  Devis Rayson; Namanya Basinda; Ruanda Adam Pius; Jeremiah Seni
Journal:  Infect Prev Pract       Date:  2021-10-23

Review 7.  Genetic Determinants of Resistance among ESBL-Producing Enterobacteriaceae in Community and Hospital Settings in East, Central, and Southern Africa: A Systematic Review and Meta-Analysis of Prevalence.

Authors:  Onduru G Onduru; Rajhab S Mkakosya; Said Aboud; Susan F Rumisha
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-06-02       Impact factor: 2.471

Review 8.  Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review.

Authors:  Bugwesa Z Katale; Gerald Misinzo; Stephen E Mshana; Harriet Chiyangi; Susana Campino; Taane G Clark; Liam Good; Mark M Rweyemamu; Mecky I Matee
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-06       Impact factor: 4.887

9.  Gut mucosal colonisation with extended-spectrum beta-lactamase producing Enterobacteriaceae in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Joseph M Lewis; Rebecca Lester; Paul Garner; Nicholas A Feasey
Journal:  Wellcome Open Res       Date:  2019-10-23

10.  High Fecal Carriage of Multidrug Resistant Bacteria in the Community among Children in Northwestern Tanzania.

Authors:  Delfina R Msanga; Vitus Silago; Tulla Massoza; Benson R Kidenya; Emmanuel Balandya; Mariam M Mirambo; Bruno Sunguya; Blandina Theophil Mmbaga; Eligius Lyamuya; John Bartlet; Stephen E Mshana
Journal:  Pathogens       Date:  2022-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.